KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) EPS (Basic) (2016 - 2025)

Cvs Health (CVS) has disclosed EPS (Basic) for 17 consecutive years, with $2.33 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 77.86% year-over-year to $2.33, compared with a TTM value of $1.4 through Dec 2025, down 61.85%, and an annual FY2025 reading of $1.4, down 61.85% over the prior year.
  • EPS (Basic) was $2.33 for Q4 2025 at Cvs Health, up from -$3.15 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $2.33 in Q4 2025 and bottomed at -$3.15 in Q3 2025.
  • Average EPS (Basic) over 5 years is $1.05, with a median of $1.44 recorded in 2024.
  • The sharpest move saw EPS (Basic) soared 167.95% in 2023, then crashed 4600.0% in 2025.
  • Year by year, EPS (Basic) stood at $1.06 in 2021, then skyrocketed by 67.92% to $1.78 in 2022, then fell by 10.67% to $1.59 in 2023, then dropped by 17.61% to $1.31 in 2024, then soared by 77.86% to $2.33 in 2025.
  • Business Quant data shows EPS (Basic) for CVS at $2.33 in Q4 2025, -$3.15 in Q3 2025, and $0.81 in Q2 2025.